1. Andreesen, R., Modolell, M., Oepke, G., Common, H., Lohr, G., andMunder, P., 1982, Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.Anticancer Research,2, 95–100.
2. Arnold, B., Reuther, R., andWeltzien, H. V., 1978, Distribution and metabolism of synthetic alkyl analogs of lysophosphatidyl-choline in mice.Biochimica et Biophysica Acta,530, 47–51.
3. Berdel, W. E., Fink, U., Egger, B., Reichert, A., Munder, P. G., andRastetter, J., 1981, Inhibition by alkyl-lysophospholipids of tritriated thymidine uptake in cells of human malignant urologic tumors.Journal of the National Cancer Institute,66, 813–817.
4. Billiau, A., Sobis, H., Eyssen, H., andVan Den Berghe, H., 1973, Non-infectious intracysternal A-type particles in a sarcoma-positive leukemia-negative mouse cell line transformed by murine sarcoma virus (M.S.V.).Archiv für die Gesamte Virusforschung,43, 345–357.
5. Bolscher, J. G. M., Schallier, D. C. C., Smets, L. A., Van Rooy, H., Collard, J. G., Bruyneel, E. A., andMareel, M. M. K., 1986, Effects of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells.Cancer Research,46, 4080–4086.